(19)
(11) EP 4 017 859 A1

(12)

(43) Date of publication:
29.06.2022 Bulletin 2022/26

(21) Application number: 20858480.5

(22) Date of filing: 25.08.2020
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 209/16; C07D 209/14
(86) International application number:
PCT/US2020/047791
(87) International publication number:
WO 2021/041407 (04.03.2021 Gazette 2021/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2019 US 201962891388 P
09.04.2020 US 202063007653 P
20.07.2020 US 202063053976 P

(71) Applicant: Caamtech, LLC
Issaquah, Washington 98027 (US)

(72) Inventor:
  • CHADEAYNE, Andrew, R.
    Issaquah, WA 98027 (US)

(74) Representative: Jacobi, Markus Alexander 
Patentanwälte Isenbruck Bösl Hörschler PartG mbB Eastsite One Seckenheimer Landstrasse 4
68163 Mannheim
68163 Mannheim (DE)

   


(54) ALKYL QUARTERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES